Gary Ingenito
Chief Tech/Sci/R&D Officer chez CATALYST PHARMACEUTICALS, INC.
Fortune : 913 505 $ au 31/03/2024
Postes actifs de Gary Ingenito
Sociétés | Poste | Début | Fin |
---|---|---|---|
CATALYST PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2015 | - |
General Counsel | - | - |
Historique de carrière de Gary Ingenito
Anciens postes connus de Gary Ingenito
Sociétés | Poste | Début | Fin |
---|---|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 01/02/2005 | 29/02/2008 |
General Counsel | 01/02/2005 | 29/02/2008 | |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/10/2003 | 01/01/2005 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | General Counsel | - | - |
Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - | - |
ONTRAK, INC. | Chief Tech/Sci/R&D Officer | 11/04/2011 | - |
Formation de Gary Ingenito
Thomas Jefferson University | Doctorate Degree |
The Johns Hopkins University | Undergraduate Degree |
University of Miami | Graduate Degree |
Sidney Kimmel Medical College | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Canada | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
General Counsel | 3 |
Corporate Officer/Principal | 2 |
Sectorielle
Consumer Services | 5 |
Health Technology | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ONTRAK, INC. | Health Services |
CATALYST PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Commercial Services |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Sandoz Pharmaceuticals Corp. |
- Bourse
- Insiders
- Gary Ingenito
- Expérience